Literature DB >> 18383377

The risk of infection associated with tumor necrosis factor alpha antagonists: making sense of epidemiologic evidence.

Daniel H Solomon1, Mark Lunt, Sebastian Schneeweiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18383377     DOI： 10.1002/art.23396

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  17 in total

1.  Biologic response modifiers to decrease inflammation: Focus on infection risks.

Authors:  Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2012-03       Impact factor: 2.253

2.  Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.

Authors:  Candace H Feldman; Francisco M Marty; Wolfgang C Winkelmayer; Hongshu Guan; Jessica M Franklin; Daniel H Solomon; Karen H Costenbader; Seoyoung C Kim
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

3.  Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.

Authors:  Carlos G Grijalva; Lang Chen; Elizabeth Delzell; John W Baddley; Timothy Beukelman; Kevin L Winthrop; Marie R Griffin; Lisa J Herrinton; Liyan Liu; Rita Ouellet-Hellstrom; Nivedita M Patkar; Daniel H Solomon; James D Lewis; Fenglong Xie; Kenneth G Saag; Jeffrey R Curtis
Journal:  JAMA       Date:  2011-11-06       Impact factor: 56.272

4.  A basic study design for expedited safety signal evaluation based on electronic healthcare data.

Authors:  Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-08       Impact factor: 2.890

5.  Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.

Authors:  Candace H Feldman; Jinoos Yazdany; Hongshu Guan; Daniel H Solomon; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-12       Impact factor: 4.794

6.  Initiation of rheumatoid arthritis treatments and the risk of serious infections.

Authors:  Carlos G Grijalva; Lisa Kaltenbach; Patrick G Arbogast; Edward F Mitchel; Marie R Griffin
Journal:  Rheumatology (Oxford)       Date:  2009-11-11       Impact factor: 7.580

7.  Staphylococcus aureus sepsis in rheumatoid arthritis.

Authors:  Michael Sams; Margaret A Olsen; Reeti Joshi; Prabha Ranganathan
Journal:  Rheumatol Int       Date:  2015-03-11       Impact factor: 2.631

8.  TNF-α Antagonist and Infection in Rheumatoid Arthritis.

Authors:  Julia F Simard; Murray A Mittleman; Nancy A Shadick; Elizabeth W Karlson
Journal:  Open J Rheumatol Autoimmune Dis       Date:  2012-05

9.  Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis.

Authors:  Rishi J Desai; Daniel H Solomon; Sebastian Schneeweiss; Goodarz Danaei; Katherine P Liao; Seoyoung C Kim
Journal:  Epidemiology       Date:  2016-05       Impact factor: 4.822

10.  Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment.

Authors:  Timothy Beukelman; Fenglong Xie; Lang Chen; John W Baddley; Elizabeth Delzell; Carlos G Grijalva; James D Lewis; Rita Ouellet-Hellstrom; Nivedita M Patkar; Kenneth G Saag; Kevin L Winthrop; Jeffrey R Curtis
Journal:  Arthritis Rheum       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.